XML 54 R41.htm IDEA: XBRL DOCUMENT
v3.23.1

Fair Value of Assets and Liabilities Fair Value of Assets and Liabilities (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2023
Fair Value Disclosures [Abstract] |
Schedule Of Fair Value Assets and Liabilities Measured on Recurring Basis Table Text Block | Assets and liabilities measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022 are summarized below (dollars in millions):
March 31, 2023: |  |  |  | Fair Value Measurements Using:
|  | Total |  | Level 1 |  | Level 2 |  | Level 3
Assets: (1) |  |  |  |  |  |  |  |
Fixed maturity securities available-for-sale: |  |  |  |  |  |  |  |
Corporate |  | $ | 35,477 |  |  | $ | — |  |  | $ | 30,864 |  |  | $ | 4,613 |
Canadian government |  | 3,755 |  |  | — |  |  | 3,755 |  |  | — |
Japanese government |  | 3,443 |  |  | — |  |  | 3,443 |  |  | — |
ABS |  | 4,103 |  |  | — |  |  | 2,699 |  |  | 1,404 |
CMBS |  | 1,670 |  |  | — |  |  | 1,614 |  |  | 56 |
RMBS |  | 1,024 |  |  | — |  |  | 1,023 |  |  | 1 |
U.S. government |  | 1,745 |  |  | 1,649 |  |  | 88 |  |  | 8 |
State and political subdivisions |  | 1,138 |  |  | — |  |  | 1,118 |  |  | 20 |
Other foreign government |  | 3,730 |  |  | — |  |  | 3,693 |  |  | 37 |
Total fixed maturity securities available-for-sale |  | 56,085 |  |  | 1,649 |  |  | 48,297 |  |  | 6,139 |
Equity securities |  | 138 |  |  | 70 |  |  | — |  |  | 68 |
Funds withheld at interest – embedded derivatives |  | (322) |  |  | — |  |  | — |  |  | (322) |
Funds withheld at interest |  | 53 |  |  | — |  |  | — |  |  | 53 |
Cash equivalents |  | 1,654 |  |  | 1,653 |  |  | — |  |  | 1 |
Short-term investments |  | 203 |  |  | 118 |  |  | 78 |  |  | 7 |
Other invested assets: |  |  |  |  |  |  |  |
Derivatives |  | 100 |  |  | — |  |  | 100 |  |  | — |
Other |  | 24 |  |  | — |  |  | 24 |  |  | — |
Total other invested assets |  | 124 |  |  | — |  |  | 124 |  |  | — |
Total |  | $ | 57,935 |  |  | $ | 3,490 |  |  | $ | 48,499 |  |  | $ | 5,946 |
Liabilities: |  |  |  |  |  |  |  |
Interest-sensitive contract liabilities – embedded derivatives |  | $ | 495 |  |  | $ | — |  |  | $ | — |  |  | $ | 495 |
Other liabilities: |  |  |  |  |  |  |  |
Funds withheld at interest – embedded derivatives |  | (351) |  |  | — |  |  | — |  |  | (351) |
Derivatives |  | 189 |  |  | — |  |  | 189 |  |  | — |
Total |  | $ | 333 |  |  | $ | — |  |  | $ | 189 |  |  | $ | 144 |
(1)Excludes limited partnerships that are measured at estimated fair value using the NAV per share (or its equivalent) as a practical expedient. As of March 31, 2023, the fair value of such investments was $726 million.
December 31, 2022: |  |  |  | Fair Value Measurements Using:
|  | Total |  | Level 1 |  | Level 2 |  | Level 3
Assets: (1) |  |  |  |  |  |  |  |
Fixed maturity securities available-for-sale: |  |  |  |  |  |  |  |
Corporate |  | $ | 33,969 |  |  | $ | — |  |  | $ | 29,670 |  |  | $ | 4,299 |
Canadian government |  | 3,626 |  |  | — |  |  | 3,626 |  |  | — |
Japanese government |  | 2,559 |  |  | — |  |  | 2,559 |  |  | — |
ABS |  | 3,878 |  |  | — |  |  | 2,603 |  |  | 1,275 |
CMBS |  | 1,623 |  |  | — |  |  | 1,555 |  |  | 68 |
RMBS |  | 941 |  |  | — |  |  | 931 |  |  | 10 |
U.S. government |  | 1,482 |  |  | 1,388 |  |  | 85 |  |  | 9 |
State and political subdivisions |  | 1,119 |  |  | — |  |  | 1,093 |  |  | 26 |
Other foreign government |  | 3,704 |  |  | — |  |  | 3,669 |  |  | 35 |
Total fixed maturity securities available-for-sale |  | 52,901 |  |  | 1,388 |  |  | 45,791 |  |  | 5,722 |
Equity securities |  | 134 |  |  | 68 |  |  | — |  |  | 66 |
Funds withheld at interest – embedded derivatives |  | (371) |  |  | — |  |  | — |  |  | (371) |
Funds withheld at interest |  | 54 |  |  | — |  |  | — |  |  | 54 |
Cash equivalents |  | 1,535 |  |  | 1,535 |  |  | — |  |  | — |
Short-term investments |  | 121 |  |  | 54 |  |  | 54 |  |  | 13 |
Other invested assets: |  |  |  |  |  |  |  |
Derivatives |  | 170 |  |  | — |  |  | 170 |  |  | — |
Other |  | 23 |  |  | — |  |  | 23 |  |  | — |
Total other invested assets |  | 193 |  |  | — |  |  | 193 |  |  | — |
Total |  | $ | 54,567 |  |  | $ | 3,045 |  |  | $ | 46,038 |  |  | $ | 5,484 |
Liabilities: |  |  |  |  |  |  |  |
Interest-sensitive contract liabilities – embedded derivatives |  | $ | 530 |  |  | $ | — |  |  | $ | — |  |  | $ | 530 |
Other liabilities: |  |  |  |  |  |  |  |
Funds withheld at interest – embedded derivatives |  | (363) |  |  | — |  |  | — |  |  | (363) |
Derivatives |  | 183 |  |  | — |  |  | 183 |  |  | — |
Total |  | $ | 350 |  |  | $ | — |  |  | $ | 183 |  |  | $ | 167 |
(1)Excludes limited partnerships that are measured at estimated fair value using the NAV per share (or its equivalent) as a practical expedient. As of December 31, 2022, the fair value of such investments was $683 million.
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] | The following table presents quantitative information about significant unobservable inputs used in Level 3 fair value measurements that are developed internally by the Company as of March 31, 2023 and December 31, 2022 (dollars in millions):
| Estimated Fair Value |  | Valuation Technique |  | Unobservable Inputs |  | Range (Weighted Average) |  |
March 31, 2023 |  | December 31, 2022 |  |  |  | March 31, 2023 |  | December 31, 2022 |  |
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate | $ | 25 |  |  | $ | 25 |  |  | Market comparable securities |  | Liquidity premium |  | 1% |  | 1% |  |
|  |  |  |  |  |  | EBITDA Multiple |  | 5.3x |  | 5.3x |  |
ABS | 272 |  |  | 274 |  |  | Market comparable securities |  | Liquidity premium |  | 0-18% (2%) |  | 0-18% (2%) |  |
U.S. government | 8 |  |  | 9 |  |  | Market comparable securities |  | Liquidity premium |  | 0-1% (1%) |  | 0-1% (1%) |  |
Equity securities | 9 |  |  | 9 |  |  | Market comparable securities |  | EBITDA Multiple |  | 8.4x-11.2x (9.7x) |  | 8.4x-11.2x (9.6x) |  |
Funds withheld at interest – embedded derivatives | 4 |  |  | (34) |  |  | Total return swap |  | Mortality |  | 0-100% (3%) |  | 0-100% (3%) |  |
|  |  |  |  |  |  | Lapse |  | 0-35% (15%) |  | 0-35% (17%) |  |
|  |  |  |  |  |  | Withdrawal |  | 0-5% (4%) |  | 0-5% (4%) |  |
|  |  |  |  |  |  | CVA |  | 0-5% (0%) |  | 0-5% (0%) |  |
|  |  |  |  |  |  | Crediting rate |  | 1-4% (2%) |  | 1-4% (2%) |  |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |
Interest-sensitive contract liabilities – embedded derivatives – indexed annuities | 495 |  |  | 530 |  |  | Discounted cash flow |  | Mortality |  | 0-100% (3%) |  | 0-100% (3%) |  |
|  |  |  |  |  |  | Lapse |  | 0-35% (14%) |  | 0-35% (16%) |  |
|  |  |  |  |  |  | Withdrawal |  | 0-5% (4%) |  | 0-5% (3%) |  |
|  |  |  |  |  |  | Option budget projection |  | 1-4% (2%) |  | 1-4% (2%) |  |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] |
For the three months ended March 31, 2023: |  | Fixed maturity securities available-for-sale |  |  |  |  |  |  |  | Funds withheld at interest –embedded derivatives, net (1) |  | Funds withheld at interest |  |  |  | Interest-sensitive contract liabilities – embedded derivatives
|  | Corporate |  | Foreign govt |  | Structured securities |  | U.S. and local govt |  | Equity securities |  | Cash equivalents |  | Short-term investments |  |  |  |
Fair value, beginning of period |  | $ | 4,299 |  |  | $ | 35 |  |  | $ | 1,353 |  |  | $ | 35 |  |  | $ | 66 |  |  | $ | — |  |  | $ | 13 |  |  | $ | (8) |  |  | $ | 54 |  |  |  |  | $ | (530) |
Total gains/losses (realized/unrealized) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Included in earnings, net: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net investment income |  | 1 |  |  | — |  |  | 1 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (2) |  |  |  |  | — |
Investment related gains (losses), net |  | (1) |  |  | — |  |  | 1 |  |  | — |  |  | — |  |  | — |  |  | (1) |  |  | 37 |  |  | — |  |  |  |  | — |
Interest credited |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | 16 |
Included in other comprehensive income (loss) |  | 55 |  |  | 2 |  |  | 33 |  |  | (1) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1 |  |  |  |  | — |
Purchases (2) |  | 318 |  |  | — |  |  | 98 |  |  | — |  |  | 2 |  |  | 1 |  |  | 1 |  |  | — |  |  | — |  |  |  |  | 2 |
Sales (2) |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | — |
Settlements (2) |  | (59) |  |  | — |  |  | (62) |  |  | (1) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | 17 |
Transfers into Level 3 |  | — |  |  | — |  |  | 64 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | — |
Transfers out of Level 3 |  | — |  |  | — |  |  | (27) |  |  | (5) |  |  | — |  |  | — |  |  | (6) |  |  | — |  |  | — |  |  |  |  | — |
Fair value, end of period |  | $ | 4,613 |  |  | $ | 37 |  |  | $ | 1,461 |  |  | $ | 28 |  |  | $ | 68 |  |  | $ | 1 |  |  | $ | 7 |  |  | $ | 29 |  |  | $ | 53 |  |  |  |  | $ | (495) |
Total gains/losses (realized/unrealized) recorded for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net investment income |  | $ | 1 |  |  | $ | — |  |  | $ | 1 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (2) |  |  |  |  | $ | — |
Investment related gains (losses), net |  | (2) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (1) |  |  | 37 |  |  | — |  |  |  |  | — |
Interest credited |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | (1) |
Included in other comprehensive income (loss) |  | 52 |  |  | 2 |  |  | 33 |  |  | (1) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1 |  |  |  |  | — |
(1)Funds withheld at interest – embedded derivatives assets and liabilities are presented net for purposes of the rollforward. (2)The amount reported within purchases, sales and settlements is the purchase price (for purchases) and the sales/settlement proceeds (for sales and settlements) based upon the actual date purchased or sold/settled. Items purchased and sold/settled in the same period are excluded from the rollforward. The Company had no issuances during the period.
For the three months ended March 31, 2022: |  | Fixed maturity securities available-for-sale |  |  |  |  |  |  |  | Funds withheld at interest –embedded derivatives, net (1) |  | Funds withheld at interest |  |  |  | Interest-sensitive contract liabilities – embedded derivatives
|  | Corporate |  | Foreign govt |  | Structured securities |  | U.S. and local govt |  | Equity securities |  | Cash equivalents |  | Short-term investments |  |  |  |
Fair value, beginning of period |  | $ | 3,888 |  |  | $ | 33 |  |  | $ | 1,179 |  |  | $ | 45 |  |  | $ | 50 |  |  | $ | — |  |  | $ | 28 |  |  | $ | 165 |  |  | $ | 83 |  |  |  |  | $ | (693) |
Total gains/losses (realized/unrealized) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Included in earnings, net: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net investment income |  | 1 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (5) |  |  |  |  | — |
Investment related gains (losses), net |  | — |  |  | — |  |  | (5) |  |  | — |  |  | (1) |  |  | — |  |  | — |  |  | (33) |  |  | — |  |  |  |  | — |
Interest credited |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | 36 |
Included in other comprehensive income (loss) |  | (144) |  |  | (4) |  |  | (72) |  |  | (1) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (2) |  |  |  |  | — |
Purchases (2) |  | 365 |  |  | — |  |  | 95 |  |  | — |  |  | — |  |  | — |  |  | 20 |  |  | — |  |  | 1 |  |  |  |  | (6) |
Sales (2) |  | (16) |  |  | — |  |  | (51) |  |  | — |  |  | (1) |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | — |
Settlements (2) |  | (26) |  |  | — |  |  | (38) |  |  | (2) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (2) |  |  |  |  | 18 |
Transfers into Level 3 |  | — |  |  | — |  |  | 13 |  |  | 6 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | — |
Transfers out of Level 3 |  | (22) |  |  | — |  |  | — |  |  | (4) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | — |
Fair value, end of period |  | $ | 4,046 |  |  | $ | 29 |  |  | $ | 1,121 |  |  | $ | 44 |  |  | $ | 48 |  |  | $ | — |  |  | $ | 48 |  |  | $ | 132 |  |  | $ | 75 |  |  |  |  | $ | (645) |
Total gains/losses (realized/unrealized) recorded for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net investment income |  | $ | 1 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (5) |  |  |  |  | $ | — |
Investment related gains (losses), net |  | — |  |  | — |  |  | (5) |  |  | — |  |  | (1) |  |  | — |  |  | — |  |  | (33) |  |  | — |  |  |  |  | — |
Claims and other policy benefits |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | — |
Interest credited |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | 18 |
Included in other comprehensive income (loss) |  | (144) |  |  | (4) |  |  | (71) |  |  | (1) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (2) |  |  |  |  | — |
(1)Funds withheld at interest – embedded derivatives assets and liabilities are presented net for purposes of the rollforward. (2)The amount reported within purchases, sales and settlements is the purchase price (for purchases) and the sales/settlement proceeds (for sales and settlements) based upon the actual date purchased or sold/settled. Items purchased and sold/settled in the same period are excluded from the rollforward. The Company had no issuances during the period.
Financial Instruments Carrying Amounts And Estimated Fair Value [Table Text Block] | The following table presents the carrying values and estimated fair values of the Company’s financial instruments, which were not measured at fair value on a recurring basis, as of March 31, 2023 and December 31, 2022 (dollars in millions). For additional information regarding the methods and significant assumptions used by the Company to estimate these fair values, see Note 6 – “Fair Value of Assets and Liabilities” in the Notes to Consolidated Financial Statements included in the Company’s 2022 Annual Report. This table excludes any payables or receivables for collateral under repurchase/reverse repurchase agreements and other transactions. The estimated fair value of the excluded amount approximates carrying value as they equal the amount of cash collateral received/paid.
March 31, 2023: |  | Carrying Value (1) |  | Estimated Fair Value |  | Fair Value Measurement Using:
Level 1 |  | Level 2 |  | Level 3 |  |
Assets: |  |  |  |  |  |  |  |  |  |  |  |
Mortgage loans |  | $ | 6,833 |  |  | $ | 6,367 |  |  | $ | — |  |  | $ | — |  |  | $ | 6,367 |  |  |
Policy loans |  | 1,221 |  |  | 1,221 |  |  | — |  |  | 1,221 |  |  | — |  |  |
Funds withheld at interest |  | 6,245 |  |  | 5,821 |  |  | — |  |  | — |  |  | 5,821 |  |  |
Limited partnerships – cost method |  | 54 |  |  | 57 |  |  | — |  |  | — |  |  | 57 |  |  |
Cash and cash equivalents |  | 1,640 |  |  | 1,640 |  |  | 1,640 |  |  | — |  |  | — |  |  |
Short-term investments |  | 43 |  |  | 43 |  |  | 43 |  |  | — |  |  | — |  |  |
Other invested assets |  | 974 |  |  | 780 |  |  | 5 |  |  | 64 |  |  | 711 |  |  |
Accrued investment income |  | 672 |  |  | 672 |  |  | — |  |  | 672 |  |  | — |  |  |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |
Interest-sensitive contract liabilities |  | $ | 23,515 |  |  | $ | 23,213 |  |  | $ | — |  |  | $ | — |  |  | $ | 23,213 |  |  |
Other liabilities – funds withheld at interest |  | 1,593 |  |  | 1,316 |  |  | — |  |  | — |  |  | 1,316 |  |  |
Long-term debt |  | 4,455 |  |  | 4,260 |  |  | — |  |  | — |  |  | 4,260 |  |  |
December 31, 2022: |  |  |  |  |  |
Assets: |  |  |  |  |  |  |  |  |  |  |  |
Mortgage loans |  | $ | 6,590 |  |  | $ | 6,109 |  |  | $ | — |  |  | $ | — |  |  | $ | 6,109 |  |  |
Policy loans |  | 1,231 |  |  | 1,231 |  |  | — |  |  | 1,231 |  |  | — |  |  |
Funds withheld at interest |  | 6,319 |  |  | 5,884 |  |  | — |  |  | — |  |  | 5,884 |  |  |
Limited partnerships – cost method |  | 49 |  |  | 52 |  |  | — |  |  | — |  |  | 52 |  |  |
Cash and cash equivalents |  | 1,392 |  |  | 1,392 |  |  | 1,392 |  |  | — |  |  | — |  |  |
Short-term investments |  | 33 |  |  | 33 |  |  | 33 |  |  | — |  |  | — |  |  |
Other invested assets |  | 947 |  |  | 758 |  |  | 4 |  |  | 65 |  |  | 689 |  |  |
Accrued investment income |  | 630 |  |  | 630 |  |  | — |  |  | 630 |  |  | — |  |  |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |
Interest-sensitive contract liabilities |  | $ | 23,493 |  |  | $ | 23,065 |  |  | $ | — |  |  | $ | — |  |  | $ | 23,065 |  |  |
Other liabilities – funds withheld at interest |  | 1,596 |  |  | 1,321 |  |  | — |  |  | — |  |  | 1,321 |  |  |
Long-term debt |  | 3,961 |  |  | 3,670 |  |  | — |  |  | — |  |  | 3,670 |  |  |
(1)Carrying values presented herein may differ from those in the Company’s condensed consolidated balance sheets because certain items within the respective financial statement captions may be measured at fair value on a recurring basis.

X
- Definition Carrying amounts and estimated fair value of financial instruments. + References No definition available. + Details
Name: | rga_FinancialInstrumentsCarryingAmountsAndEstimatedFairValueTableTextBlock
Namespace Prefix: | rga_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb) -SubTopic 10 -Topic 820 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c) -SubTopic 10 -Topic 820 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3 + Details
Name: | us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration